Search tips
Search criteria 


Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
Antimicrob Agents Chemother. 1991 September; 35(9): 1697–1704.
PMCID: PMC245253

More extended-spectrum beta-lactamases.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Arlet G, Sanson-le Pors MJ, Rouveau M, Fournier G, Marie O, Schlemmer B, Philippon A. Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 beta-lactamase. Eur J Clin Microbiol Infect Dis. 1990 Nov;9(11):797–803. [PubMed]
  • Barthélémy M, Péduzzi J, Ben Yaghlane H, Labia R. Single amino acid substitution between SHV-1 beta-lactamase and cefotaxime-hydrolyzing SHV-2 enzyme. FEBS Lett. 1988 Apr 11;231(1):217–220. [PubMed]
  • Barthélémy M, Peduzzi J, Labia R. Distinction entre les structures primaires des beta-lactamases TEM-1 et TEM-2. Ann Inst Pasteur Microbiol. 1985 May-Jun;136A(3):311–321. [PubMed]
  • Barthélémy M, Peduzzi J, Labia R. Complete amino acid sequence of p453-plasmid-mediated PIT-2 beta-lactamase (SHV-1). Biochem J. 1988 Apr 1;251(1):73–79. [PubMed]
  • Bauernfeind A. Perspectives of beta-lactamases inhibitors in therapy of infections caused by Escherichia coli or Klebsiella with plasmidic resistance to third generation cephalosporins. Infection. 1990 Jan-Feb;18(1):48–52. [PubMed]
  • Bauernfeind A, Chong Y, Schweighart S. Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection. 1989 Sep-Oct;17(5):316–321. [PubMed]
  • Bauernfeind A, Grimm H, Schweighart S. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection. 1990 Sep-Oct;18(5):294–298. [PubMed]
  • Bauernfeind A, Hörl G. Novel R-factor borne beta-lactamase of Escherichia coli confering resistance to cephalosporins. Infection. 1987 Jul-Aug;15(4):257–259. [PubMed]
  • Ben Redjeb S, Fournier G, Mabilat C, Ben Hassen A, Philippon A. Two novel transferable extended-spectrum beta-lactamases from Klebsiella pneumoniae in Tunisia. FEMS Microbiol Lett. 1990 Jan 15;55(1-2):33–38. [PubMed]
  • Billot-Klein D, Gutmann L, Collatz E. Nucleotide sequence of the SHV-5 beta-lactamase gene of a Klebsiella pneumoniae plasmid. Antimicrob Agents Chemother. 1990 Dec;34(12):2439–2441. [PMC free article] [PubMed]
  • Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Duval J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet. 1987 Aug 8;2(8554):302–306. [PubMed]
  • Buré A, Legrand P, Arlet G, Jarlier V, Paul G, Philippon A. Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam. Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):780–782. [PubMed]
  • Bush K, Singer SB. Biochemical characteristics of extended broad spectrum beta-lactamases. Infection. 1989 Nov-Dec;17(6):429–433. [PubMed]
  • Caron F, Gutmann L, Bure A, Pangon B, Vallois JM, Pechinot A, Carbon C. Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase. Antimicrob Agents Chemother. 1990 Nov;34(11):2070–2074. [PMC free article] [PubMed]
  • Casellas JM, Goldberg M. Incidence of strains producing extended spectrum beta-lactamases in Argentina. Infection. 1989 Nov-Dec;17(6):434–436. [PubMed]
  • Chanal CM, Sirot DL, Petit A, Labia R, Morand A, Sirot JL, Cluzel RA. Multiplicity of TEM-derived beta-lactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationships between the responsible plasmids. Antimicrob Agents Chemother. 1989 Nov;33(11):1915–1920. [PMC free article] [PubMed]
  • Christensen H, Martin MT, Waley SG. Beta-lactamases as fully efficient enzymes. Determination of all the rate constants in the acyl-enzyme mechanism. Biochem J. 1990 Mar 15;266(3):853–861. [PubMed]
  • Collatz E, Tran Van Nhieu G, Billot-Klein D, Williamson R, Gutmann L. Substitution of serine for arginine in position 162 of TEM-type beta-lactamases extends the substrate profile of mutant enzymes, TEM-7 and TEM-101, to ceftazidime and aztreonam. Gene. 1989 May 30;78(2):349–354. [PubMed]
  • Datta N, Kontomichalou P. Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae. Nature. 1965 Oct 16;208(5007):239–241. [PubMed]
  • Fantin B, Pangon B, Potel G, Caron F, Vallée E, Vallois JM, Mohler J, Buré A, Philippon A, Carbon C. Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase. Antimicrob Agents Chemother. 1990 Apr;34(4):581–586. [PMC free article] [PubMed]
  • Garbarg-Chenon A, Godard V, Labia R, Nicolas JC. Nucleotide sequence of SHV-2 beta-lactamase gene. Antimicrob Agents Chemother. 1990 Jul;34(7):1444–1446. [PMC free article] [PubMed]
  • Gutmann L, Ferré B, Goldstein FW, Rizk N, Pinto-Schuster E, Acar JF, Collatz E. SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob Agents Chemother. 1989 Jun;33(6):951–956. [PMC free article] [PubMed]
  • Gutmann L, Kitzis MD, Billot-Klein D, Goldstein F, Tran Van Nhieu G, Lu T, Carlet J, Collatz E, Williamson R. Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam. Rev Infect Dis. 1988 Jul-Aug;10(4):860–866. [PubMed]
  • Herzberg O, Moult J. Bacterial resistance to beta-lactam antibiotics: crystal structure of beta-lactamase from Staphylococcus aureus PC1 at 2.5 A resolution. Science. 1987 May 8;236(4802):694–701. [PubMed]
  • Huletsky A, Couture F, Levesque RC. Nucleotide sequence and phylogeny of SHV-2 beta-lactamase. Antimicrob Agents Chemother. 1990 Sep;34(9):1725–1732. [PMC free article] [PubMed]
  • Jacoby GA, Carreras I. Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1990 May;34(5):858–862. [PMC free article] [PubMed]
  • Jacoby GA, Medeiros AA, O'Brien TF, Pinto ME, Jiang H. Broad-spectrum, transmissible beta-lactamases. N Engl J Med. 1988 Sep 15;319(11):723–724. [PubMed]
  • Jacoby GA, Sutton L. Properties of plasmids responsible for production of extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1991 Jan;35(1):164–169. [PMC free article] [PubMed]
  • Kitzis MD, Liassine N, Ferré B, Gutmann L, Acar JF, Goldstein F. In vitro activities of 15 oral beta-lactams against Klebsiella pneumoniae harboring new extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1990 Sep;34(9):1783–1786. [PMC free article] [PubMed]
  • Kliebe C, Nies BA, Meyer JF, Tolxdorff-Neutzling RM, Wiedemann B. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1985 Aug;28(2):302–307. [PMC free article] [PubMed]
  • Labia R, Morand A, Tiwari K, Sirot J, Sirot D, Petit A. Interactions of new plasmid-mediated beta-lactamases with third-generation cephalosporins. Rev Infect Dis. 1988 Jul-Aug;10(4):885–891. [PubMed]
  • Lee KY, Hopkins JD, Syvanen M. Direct involvement of IS26 in an antibiotic resistance operon. J Bacteriol. 1990 Jun;172(6):3229–3236. [PMC free article] [PubMed]
  • Lowbury EJ, Lilly HA, Kidson A, Ayliffe GA, Jones RJ. Sensitivity of Pseudomonas aeruginosa to antibiotics: emergence of strains highly resistant to carbenicillin. Lancet. 1969 Aug 30;2(7618):448–452. [PubMed]
  • Mabilat C, Courvalin P. Development of "oligotyping" for characterization and molecular epidemiology of TEM beta-lactamases in members of the family Enterobacteriaceae. Antimicrob Agents Chemother. 1990 Nov;34(11):2210–2216. [PMC free article] [PubMed]
  • Matsumoto Y, Ikeda F, Kamimura T, Yokota Y, Mine Y. Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins. Antimicrob Agents Chemother. 1988 Aug;32(8):1243–1246. [PMC free article] [PubMed]
  • Matthew M, Hedges RW, Smith JT. Types of beta-lactamase determined by plasmids in gram-negative bacteria. J Bacteriol. 1979 Jun;138(3):657–662. [PMC free article] [PubMed]
  • Mercier J, Levesque RC. Cloning of SHV-2, OHIO-1, and OXA-6 beta-lactamases and cloning and sequencing of SHV-1 beta-lactamase. Antimicrob Agents Chemother. 1990 Aug;34(8):1577–1583. [PMC free article] [PubMed]
  • Nicolas MH, Jarlier V, Honore N, Philippon A, Cole ST. Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother. 1989 Dec;33(12):2096–2100. [PMC free article] [PubMed]
  • Pangon B, Bizet C, Buré A, Pichon F, Philippon A, Regnier B, Gutmann L. In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase. J Infect Dis. 1989 May;159(5):1005–1006. [PubMed]
  • Papanicolaou GA, Medeiros AA. Discrimination of extended-spectrum beta-lactamases by a novel nitrocefin competition assay. Antimicrob Agents Chemother. 1990 Nov;34(11):2184–2192. [PMC free article] [PubMed]
  • Papanicolaou GA, Medeiros AA, Jacoby GA. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother. 1990 Nov;34(11):2200–2209. [PMC free article] [PubMed]
  • Paul GC, Gerbaud G, Bure A, Philippon AM, Pangon B, Courvalin P. TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli. Antimicrob Agents Chemother. 1989 Nov;33(11):1958–1963. [PMC free article] [PubMed]
  • Payne DJ, Amyes SG. Transferable resistance to extended-spectrum beta-lactams: a major threat or a minor inconvenience? J Antimicrob Chemother. 1991 Mar;27(3):255–261. [PubMed]
  • Payne DJ, Blakemore PH, Drabu YJ, Amyes SG. Comparison of TEM-E3 and TEM-5 beta-lactamases. J Antimicrob Chemother. 1989 Oct;24(4):615–617. [PubMed]
  • Payne DJ, Hood J, Marriott MS, Amyes SG. Separation of plasmid-mediated extended spectrum beta-lactamases by fast protein liquid chromatography (FPLC system). FEMS Microbiol Lett. 1990 Jun 1;57(3):195–200. [PubMed]
  • Payne DJ, Marriott MS, Amyes SG. TEM-E1: a novel beta-lactamase conferring resistance to ceftazidime. FEMS Microbiol Lett. 1989 May;50(1-2):97–100. [PubMed]
  • Payne DJ, Marriott MS, Amyes SG. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2. J Med Microbiol. 1990 Jun;32(2):131–134. [PubMed]
  • Péduzzi J, Barthélémy M, Tiwari K, Mattioni D, Labia R. Structural features related to hydrolytic activity against ceftazidime of plasmid-mediated SHV-type CAZ-5 beta-lactamase. Antimicrob Agents Chemother. 1989 Dec;33(12):2160–2163. [PMC free article] [PubMed]
  • Petit A, Gerbaud G, Sirot D, Courvalin P, Sirot J. Molecular epidemiology of TEM-3 (CTX-1) beta-lactamase. Antimicrob Agents Chemother. 1990 Feb;34(2):219–224. [PMC free article] [PubMed]
  • Petit A, Sirot DL, Chanal CM, Sirot JL, Labia R, Gerbaud G, Cluzel RA. Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1988 May;32(5):626–630. [PMC free article] [PubMed]
  • Philippon A, Ben Redjeb S, Fournier G, Ben Hassen A. Epidemiology of extended spectrum beta-lactamases. Infection. 1989 Sep-Oct;17(5):347–354. [PubMed]
  • Philippon A, Labia R, Jacoby G. Extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1989 Aug;33(8):1131–1136. [PMC free article] [PubMed]
  • Philippon A, Paul G, Vedel G, Nevot P. Résistance plasmidique aux céphalosporines de 3e génération. Presse Med. 1988 Oct 26;17(37):1883–1889. [PubMed]
  • Podbielski A, Melzer B. Nucleotide sequence of the gene encoding the SHV-2 beta-lactamase (blaSHV-2) of Klebsiella ozaenae. Nucleic Acids Res. 1990 Aug 25;18(16):4916–4916. [PMC free article] [PubMed]
  • Quinn JP, Miyashiro D, Sahm D, Flamm R, Bush K. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother. 1989 Sep;33(9):1451–1456. [PMC free article] [PubMed]
  • Rice LB, Willey SH, Papanicolaou GA, Medeiros AA, Eliopoulos GM, Moellering RC, Jr, Jacoby GA. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother. 1990 Nov;34(11):2193–2199. [PMC free article] [PubMed]
  • Rice LB, Yao JD, Klimm K, Eliopoulos GM, Moellering RC., Jr Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model. Antimicrob Agents Chemother. 1991 Jun;35(6):1243–1244. [PMC free article] [PubMed]
  • Sanders CC. Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics. Annu Rev Microbiol. 1987;41:573–593. [PubMed]
  • Shannon KP, King A, Phillips I, Nicolas MH, Philippon A. Importance of organisms producing broad-spectrum SHV-group beta-lactamases into the United Kingdom. J Antimicrob Chemother. 1990 Mar;25(3):343–351. [PubMed]
  • Sirot D, Chanal C, Labia R, Meyran M, Sirot J, Cluzel R. Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniae. J Antimicrob Chemother. 1989 Oct;24(4):509–521. [PubMed]
  • Sirot D, Sirot J, Labia R, Morand A, Courvalin P, Darfeuille-Michaud A, Perroux R, Cluzel R. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. J Antimicrob Chemother. 1987 Sep;20(3):323–334. [PubMed]
  • Smith CE, Tillman BS, Howell AW, Longfield RN, Jorgensen JH. Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase. Antimicrob Agents Chemother. 1990 Jun;34(6):1290–1293. [PMC free article] [PubMed]
  • Sougakoff W, Petit A, Goussard S, Sirot D, Bure A, Courvalin P. Characterization of the plasmid genes blaT-4 and blaT-5 which encode the broad-spectrum beta-lactamases TEM-4 and TEM-5 in enterobacteriaceae. Gene. 1989 May 30;78(2):339–348. [PubMed]
  • Sowek JA, Singer SB, Ohringer S, Malley MF, Dougherty TJ, Gougoutas JZ, Bush K. Substitution of lysine at position 104 or 240 of TEM-1pTZ18R beta-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam. Biochemistry. 1991 Apr 2;30(13):3179–3188. [PubMed]
  • Spencer RC, Wheat PF, Winstanley TG, Cox DM, Plested SJ. Novel beta-lactamase in a clinical isolate of Klebsiella pneumoniae conferring unusual resistance to beta-lactam antibiotics. J Antimicrob Chemother. 1987 Dec;20(6):919–921. [PubMed]
  • Sutcliffe JG. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3737–3741. [PubMed]
  • Thomson KS, Sanders CC, Washington JA., 2nd High-level resistance to cefotaxime and ceftazidime in Klebsiella pneumoniae isolates from Cleveland, Ohio. Antimicrob Agents Chemother. 1991 May;35(5):1001–1003. [PMC free article] [PubMed]
  • Vatopoulos AC, Philippon A, Tzouvelekis LS, Komninou Z, Legakis NJ. Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J Antimicrob Chemother. 1990 Nov;26(5):635–648. [PubMed]
  • Vuye A, Verschraegen G, Claeys G. Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime. Antimicrob Agents Chemother. 1989 May;33(5):757–761. [PMC free article] [PubMed]
  • Watanabe M, Iyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1991 Jan;35(1):147–151. [PMC free article] [PubMed]
  • Weber DA, Sanders CC, Bakken JS, Quinn JP. A novel chromosomal TEM derivative and alterations in outer membrane proteins together mediate selective ceftazidime resistance in Escherichia coli. J Infect Dis. 1990 Aug;162(2):460–465. [PubMed]
  • Woodford N, Payne DJ, Johnson AP, Weinbren MJ, Perinpanayagam RM, George RC, Cookson BD, Amyes SG. Transferable cephalosporin resistance not inhibited by clavulanate in Escherichia coli. Lancet. 1990 Jul 28;336(8709):253–253. [PubMed]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)